Skip to main content


Multiple Myeloma

Featured

Guideline Updates
NCCN released an update to its clinical practice guideline for multiple myeloma, adding melphalan flufenamide/dexamethasone as a category 2A recommendation for previously treated…
Quiz
True or False: DRd yielded faster and sustained clinically meaningful improvements in PROs compared with Rd for…
Videos
Tony Blau, MD, Founder and CEO, provides a demonstration of All4Cure, discusses the vision and need for the platform,…
News
Daratumumab, lenalidomide, and dexamethasone (DRd) yielded faster and sustained clinically meaningful improvements in…
Special Reports
While there is no cure for MM, a number of treatments are in the research and development pipeline. Clinicians are…
Back to Top